1. A Nanogram Dose of the CYP3A Probe Substrate Midazolam to Evaluate Drug Interactions. Issue 6 (8th February 2013) Authors: Halama, B; Hohmann, N; Burhenne, J; Weiss, J; Mikus, G; Haefeli, W E Journal: Clinical pharmacology & therapeutics Issue: Volume 93:Issue 6(2013) Page Start: 564 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comparison of the antiarrhythmic potential of doxapram and its metabolite ketodoxaparam. (3rd October 2022) Authors: Kraft, M; Wiedmann, F; Foerster, K I; Sauter, M; Paasche, A; Blochberger, P L; Yesilgoez, B; L'hoste, Y; Arif, R; Warnecke, G; Karck, M; Frey, N; Burhenne, J; Haefeli, W E; Schmidt, C Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. CYP2C9 Polymorphism is not a Major Determinant of Bosentan Exposure in Healthy Volunteers. Issue 3 (18th September 2013) Authors: Markert, C; Burhenne, J; Weiss, J; Mikus, G; Haefeli, WE Journal: Clinical pharmacology & therapeutics Issue: Volume 95:Issue 3(2014) Page Start: 250 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. O35 Midazolam pharmacokinetics in children with obesity. Issue 6 (17th May 2019) Authors: Gade, C; Sverrisdóttir, E; Dalhoff, K; Sonne, J; Rolighed Christensen, H; Burhenne, J; Mikus, G; Holm, J-C; Meldgaard Lund, T; Holst, H Journal: Archives of disease in childhood Issue: Volume 104:Issue 6(2019) Page Start: e15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. The NTCP‐inhibitor Myrcludex B: Effects on Bile Acid Disposition and Tenofovir Pharmacokinetics. Issue 2 (21st June 2017) Authors: Blank, A; Eidam, A; Haag, M; Hohmann, N; Burhenne, J; Schwab, M; van de Graaf, SFJ; Meyer, MR; Maurer, HH; Meier, K; Weiss, J; Bruckner, T; Alexandrov, A; Urban, S; Mikus, G; Haefeli, WE Journal: Clinical pharmacology & therapeutics Issue: Volume 103:Issue 2(2018) Page Start: 341 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗